Su H. Lum

Newcastle Upon Tyne, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications

Treosulfan-fludarabine conditioning in infants with severe combined immunodeficiencies: Extended study of the UK paediatric treosulfan study.

Treosulfan-fludarabine conditioning in infants with severe combined immunodeficiencies: Extended study of the UK paediatric treosulfan study.

Journal: British journal of haematology
Published: October 27, 2025

Expanding the Spectrum of Src-Family Kinase-Related Autoinflammatory Diseases: Monogenic Vasculitis Caused By Germline Pathogenic Variants in HCK and FGR.

Expanding the Spectrum of Src-Family Kinase-Related Autoinflammatory Diseases: Monogenic Vasculitis Caused By Germline Pathogenic Variants in HCK and FGR.

Journal: Journal of clinical immunology
Published: October 06, 2025

Treosulfan-fludarabine-based conditioning was associated with favourable event-free survival and very low risk of endothelial cell dysfunction in paediatric patients with non-malignant haematological disorders: Analysis of the UK Paediatric Treosulfan Study.

Treosulfan-fludarabine-based conditioning was associated with favourable event-free survival and very low risk of endothelial cell dysfunction in paediatric patients with non-malignant haematological disorders: Analysis of the UK Paediatric Treosulfan Study.

Journal: British journal of haematology
Published: May 23, 2025

Low rates of endothelial cell dysfunction and transplant-related mortality in 537 children receiving fludarabine-treosulfan conditioning for all transplant indications: A retrospective multicentre study on behalf of the UK Paediatric BMT group.

Low rates of endothelial cell dysfunction and transplant-related mortality in 537 children receiving fludarabine-treosulfan conditioning for all transplant indications: A retrospective multicentre study on behalf of the UK Paediatric BMT group.

Journal: British journal of haematology
Published: March 10, 2025

Outcome of second conditioned allogeneic stem cell transplant in children with non-SCID inborn errors of immunity.

Outcome of second conditioned allogeneic stem cell transplant in children with non-SCID inborn errors of immunity.

Journal: Blood advances
Published: January 21, 2025

HLA-haploidentical stem cell transplantation for chronic granulomatous disease: an EBMT-IEWP retrospective study.

HLA-haploidentical stem cell transplantation for chronic granulomatous disease: an EBMT-IEWP retrospective study.

Journal: Blood
Published: September 12, 2024

Hematopoietic stem cell transplantation for CTLA-4 insufficiency across Europe: A European Society for Blood and Marrow Transplantation Inborn Errors Working Party study.

Hematopoietic stem cell transplantation for CTLA-4 insufficiency across Europe: A European Society for Blood and Marrow Transplantation Inborn Errors Working Party study.

Journal: The Journal of allergy and clinical immunology
Published: May 21, 2024

CD3+TCRαβ/CD19+-depleted stem cell boost and CD45RO+ memory T-cell add-back as a successful salvage treatment for poor graft function unresponsive to eltrombopag, following a second allogenic HSCT.

CD3+TCRαβ/CD19+-depleted stem cell boost and CD45RO+ memory T-cell add-back as a successful salvage treatment for poor graft function unresponsive to eltrombopag, following a second allogenic HSCT.

Journal: Pediatric blood & cancer
Published: May 19, 2024

Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity.

Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity.

Journal: Blood
Published: January 22, 2024

Outcomes of Hematopoietic Stem Cell Transplantation in 5 Patients with Autosomal Recessive RIPK1-Deficiency.

Outcomes of Hematopoietic Stem Cell Transplantation in 5 Patients with Autosomal Recessive RIPK1-Deficiency.

Journal: Journal of clinical immunology
Published: December 28, 2023

Outcomes of hematopoietic stem cell transplantation in 813 pediatric patients with Fanconi anemia.

Outcomes of hematopoietic stem cell transplantation in 813 pediatric patients with Fanconi anemia.

Journal: Blood
Published: October 19, 2023

Alemtuzumab, Dual Graft-versus-Host Disease Prophylaxis, and Lower CD3+ T Cell Doses Equalize Rates of Acute and Chronic Graft-versus-Host Disease in Pediatric Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation with Matched Unrelated Donor Peripheral Blood Stem Cells or Bone Marrow Grafts.

Alemtuzumab, Dual Graft-versus-Host Disease Prophylaxis, and Lower CD3+ T Cell Doses Equalize Rates of Acute and Chronic Graft-versus-Host Disease in Pediatric Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation with Matched Unrelated Donor Peripheral Blood Stem Cells or Bone Marrow Grafts.

Journal: Transplantation and cellular therapy
Published: September 09, 2023
Showing 1-12 of 62

Last Updated: 09/26/2026